Structural Genomics Consortium announces two new academic partners, the Montreal Neurological Institute-Hospital and University College London

Toronto, February 25, 2022 - The Structural Genomics Consortium (SGC) is excited to welcome the Montreal Neurological Institute-Hospital (The Neuro) at McGill University and Open Chemistry Networks (OCN) based at University College London (UCL) as its latest academic partners.

SGC is pleased to have The Neuro and UCL officially contribute to our academic network, adopting SGC’s “patent-free” open science model for their SGC-associated teams.

The focus of the SGC-Neuro team will explore “dark genome” protein targets implicated in neurological diseases, as well as the creation of chemical and biological tools – from antibodies to cell lines.  The goal of the project is to understand how these genetic hits connect mechanistically. Dr. Edward Fon, Scientific Director of The Neuro and a clinician-scientist practicing in the area of Parkinson’s disease and movement disorders, will oversee the SGC-Neuro program.

The SGC-UCL team will oversee the new Open Chemistry Networks initiative, which is an innovative new collaboration that aims to bring together synthetic chemists worldwide and SGC biochemistry to synthesize and characterize new chemical probes, which will be used to accelerate the search for new medicines and biology. This program will be led by Dr. Matthew Todd, Chair of Drug Discovery in UCL’s School of Pharmacy.

These partnerships are examples of the kind of open collaboration that exist within SGC’s large network of scientists, consisting of a diverse ecosystem rooted in both academia and industry. SGC CEO, Aled Edwards, comments on these recent partnerships stating, “We are incredibly pleased to have both McGill and University College London join SGC as official partners. The breadth of their expertise strengthens SGC's open-access scientific network, and we look forward to making many scientific discoveries together.”

The addition of these two new academic partners signifies an exciting new chapter for SGC in its growth and evolution, as the organization expands through partnerships and international collaborations to advance the open science mission.


For further information about SGC, please contact:

Jill Kinsella

Director of Communications


For further information about the Montreal Neurological Institute-Hospital (The Neuro), please contact:

Shawn Hayward

Communications Officer


For further information about University College London, please contact:

Julia Weston

Head of Marketing and Communication



glqxz9283 sfy39587stf02 mnesdcuix8